The Aftermath of a 'Miracle Cure' for a Rare Cancer

In 2001, Gleevec was approved as a treatment for chronic myelogenous leukemia. It was a revelation for personalized medicine—with harrowing financial repercussions that persist today.

from Wired https://ift.tt/9BENlwn

Comments

Popular posts from this blog

F1 live stream: how to watch every 2021 Grand Prix online from anywhere

Best blogging sites of 2021: Free and paid blog platforms

Tableau launches new enterprise plans, big data tools